15.12.2014 • News

DuPont Finalizes Sale of Neoprene to Denka

DuPont Performance Polymers has finalized the terms of its sale of the Neoprene polychloroprene business to Japan's Denka Performance Elastomer, a 70:30 joint venture of Denka Kagaku Kogyo and Mitsui.

The transaction is expected to close in the first half of 2015, pending regulatory approvals. Financial terms are not being disclosed. About 235 US-based employees will transfer to the new owner.

Denka Performance Elastomer manufactures and distributes chemical products encompassing chloroprene rubber, organic and inorganic materials, polymer processing, electronic materials and pharmaceuticals.

Invented by DuPont in 1931, Neoprene is used in many chemical and weather resistant products such as wet suits and orthopedic braces, and also as a base resin in adhesives, electrical insulation and coatings.

"Neoprene has been an important product line within the DuPont Performance Polymers segment, and we believe it will truly thrive as part of the Denka Performance Elastomer portfolio," said the segment's president Patrick Linder.

Linder said that the deal also enables DuPont to focus on "innovative new offerings that drive profitable growth both today and over the long term."

Denka president Shinsuke Yoshitaka said the new Japanese owner expects the DuPont buy to provide synergies with its research and development and technical services.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read